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BIOMEDICAL TREATMENT FOR PDD-NOS; A VALID MEDICAL EXPENDITURE.
INTRODUCTION
Recent movements in health insurance reform have moved away from actuarial fairness,
which accesses the cost of insurance according to the individual risk of sickness, and towards a
system based on social solidarity, which distributes insurance cost evenly across society.1
Providing an individual with access to universal healthcare, will lower health care costs because
services will be easily accessible without lapses in care.2 Expanding health coverage will protect
society from risks, which are undiscriminating, such as unpredictable and severe lifelong
disorders such as Autism.3 Seamless health insurance coverage for an individual’s entire life has
yet to be achieved, but providing more comprehensive coverage for services needed to treat
lifelong disorders like autism may be more readily achievable.
To date, susceptibility of having a child with Autism is relatively undeterminable and as
a result, society as a whole is equally vulnerable to this lifelong disorder, and the expensive

1

Hoffman, S. Unmanaged Care: Towards moral fairness in health care coverage. Available at,
http://www.ncbi.nlm.nih.gov/pubmed/15214342. See also, Tom Baker. Health Insurance, Risk, and Responsibility
After the Patient Protection and Affordable Care Act. University of Pennsylvania law Review. Available at,
http://www.pennumbra.com/issues/pdfs/159-6/Baker.pdf.
2

Deborah Stone. The Struggle for the Soul of Health Insurance. Brandeis University. The Journal of Health
Politics, Policy and law. Available at, http://myweb.shu.edu/bbcswebdav/pid-2452936-dt-content-rid4320224_2/courses/2012_SPRING_HLTH7408MM/Stone%20Struggle%20for%20the%20Soul%20of%20HI%209
3%20excerpt.pdf (Positing that the most beneficial universal health coverage means coverage lasting for the entire
lifespan of the individual).
3
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treatments it requires.4 Thus, health insurance coverage should be expanded to provide
comprehensive access to treatments for autism because of society’s collective vulnerability to
this particular illness. Insurance providers have avoided covering Autism treatments because
treating Autism is a heavy financial burden. Treatment can run as much as $72,000 for one child
per year, or over 3.2 million over the course of that child’s lifespan.5 Still, allocating this
expense evenly across society is the most reasonable and fair approach because we cannot yet
determine exactly who will have a child with Autism and should one have a child with this
lifelong disorder, that person will want easy and comprehensive access to treatment. Further,
implementing a system, which allocates the expense for Autism treatment evenly will only
slightly increase insurance rates overall.6 Importantly, mandating broader insurance coverage for
treating Autism will result in larger gains earlier in the child’s development, which will result in
higher levels of independent living during the child’s adult life, thus, lowering society’s burden

4

Looking at family history may be indicative of a likelihood of having a child with Autism Spectrum Disorder
(ASD). Genetics may play a role in being able to determine if one is more likely to have a child with Autism. For
example, Parents with one child with autism are more likely to have autistic children in the future.
http://autismnow.org/at-home/family/multiple-children-with-autism/. See also, Autism and Genetics. The Tech
Museum of Innovation. Available at, http://genetics.thetech.org/original_news/news49 (“If you have one child with
autism, the risk for the next child is only 2-6% … if you have two children with autism, the chances that the third
will be autistic are around 35%”). See also, John Constantino. Sibling Recurrence and the Genetic Epidemiology of
Autism. Available at, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970737/ (families with autistic children had
an occurrence of ASD in a sibling 10.9% of the time and “20% of non ASD affected siblings had a history of
language delay half of which exhibited autistic qualities of speech.”).
5

Anna Satz. Overcoming Fragmentation in Health and Disability Law. 60 Emory L. J. 277 (2011). Health insurance
coverage based on universal vulnerability to illness. See also, Data & Statistics. Center for Disease Control.
Avaiable at, http://www.cdc.gov/ncbddd/autism/data.html. (estimates behavioral therapies to cost between 40 and
60 thousand per year and medical costs between 4 and 6 thousand per year for a child with ASD).
6

Autism. Centers for Disease Control and Prevention. http://www.cdc.gov/ncbddd/autism/data.html. See, Walecia
Konrad. Dealing With the Financial Burden of Autism. The New York Times. Available at,
http://www.nytimes.com/2010/01/23/health/23patient.html?_r=1&pagewanted=all.
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of supporting adults with Autism, through programs such as SSI7 or SSDI.8 Specifically,
comprehensive early intervention programs lessen the average cost of care, which is 3 to 5
million per child, by two thirds.9 Important to creating a comprehensive treatment plan for
autism is incorporating innovative approaches, such as biomedical treatment.
Autism is a neurological disorder resulting in global delays in a child’s adolescent
development.10 Autism detrimentally affects a child’s physical, mental, and social capabilities
and significantly impairs a child’s daily functioning.11 If a child has a speech delay or disorder
and physical coordination issues, as well as, an aversion to typical social behavior for a child of
like age, the combination of all of those factors may indicate the child has Autism Spectrum
Disorder (ASD).12 Autism is a spectrum disorder, meaning that children diagnosed with ASD
will have varying severity of their impairments.13 A child with the most severe diagnosis of
Autism suffers from substantial barriers in all three areas of development; physical, mental, and

7

“The Social Security Income (SSI) program pays benefits to disabled adults and children who have limited income
and resources.” U.S. Social Security Administration. Available at, http://www.ssa.gov/pgm/ssi.htm.
8

Social Security and Supplemental Security Income Disability Programs. U.S. Social Security Administration.
Available at, http://www.ssa.gov/disability/ (“The Social Security and Supplemental Security Income disability
programs are the largest of several Federal programs that provide assistance to people with disabilities. While these
two programs are different in many ways, both are administered by the Social Security Administration and only
individuals who have a disability and meet medical criteria may qualify for benefits under either program.”).
9

See, The Budget Crisis. Autism Society. Available at, http://www.autism-society.org/get-involved/the-budgetcrisis.html.
10

Autism Fact Sheet. National Institute of Neurological Disorders and Stroke. National Institutes of Health. Last
updated October 17, 2012. Available at, http://www.ninds.nih.gov/disorders/autism/detail_autism.htm.
11

Autism Spectrum Disorders (ASDs). Centers for Disease Control and Prevention. Available at,
http://www.cdc.gov/NCBDDD/autism/facts.html.
12

Autism Fact Sheet. National Institute of Neurological Disorders and Stroke. National Institutes of Health. Last
updated October 17, 2012. Available at, http://www.ninds.nih.gov/disorders/autism/detail_autism.htm
13
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emotional.14 Alternatively, a diagnosis of Asperger’s is still considered ASD but includes
children with higher cognitive ability, sometimes with exceptional ability in a particular area of
study, but with rather significant social impairments.15 This article will focus on a third ASD
diagnosis called Pervasive Developmental Disorder – Not Otherwise Specified (PDD-NOS),
which typically includes children suffering from a combination of two impairment categories.16
Typically children diagnosed with PDD-NOS are also considered “high functioning.”17
This article focuses on PDD-NOS because these children are high functioning, and have
the potential to become full independent significantly reducing the number of adults with ASD
requiring expensive treatment. Children with PDD-NOS are a subset of the total population of
children with ASD, and while biomedical treatment will help all children with ASD to progress,
biomedical treatment in combination with other services for children with PDD-NOS could
potentially result in that child becoming fully recovered, or no longer classified as ASD or
needing special services and treatments.18

14

Autism Spectrum Disorders (ASDs). Centers for Disease Control and Prevention. Available at,
http://www.cdc.gov/NCBDDD/autism/facts.html.
15

Id.

16

What is PDD-NOS? Autism Speaks Inc. Available at, http://www.autismspeaks.org/what-autism/pdd-nos.

17

Id.

18

See, Incidence of Autism. Autism-Help.org. Available at, http://www.autism-help.org/autism-incidenceincrease.htm. See also, Study suggests kids can ‘recover’ from autism. Copyright 2009 The Associated Press.
Avaialble at, http://www.msnbc.msn.com/id/30645770/ns/health-mental_health/t/study-suggests-kids-can-recoverautism/#.UPXlOHfn-So. In 2007 PDD-NOS was thought to be more prevalent than a diagnosis of sever autism, and
thus by providing expanded treatments that can help recover children with pdd-nos and allow them to be fully
functioning independent adults, we can significantly reduce the overall health insurance costs for autism treatments
within the autism community.
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Treatment for PDD-NOS does not necessitate the most intense therapies reserved to treat
severe autism, such as ABA therapy.19 Nonetheless, children with PDD-NOS do benefit from a
combination of services now generally used to treat ASD’s such as Speech Therapy (ST),
Occupational Therapy (OT), and Physical Therapy (PT).20 For the most effective treatment these
traditional services should be implemented in conjunction with, other less traditional therapies.21
There is no prevention or a cure for autism, but early intervention with a combination of various
therapies has shown to significantly reduce the symptoms and impairments inflicting children
with PDD-NOS.22 Particularly, many in the autism community have advocated that including
biomedical treatment as a part of an early intervention program is beneficial for children with
PDD-NOS.23
Biomedical treatment for autism reduces symptoms associated with one's inability to
tolerate environmental stressors.24 Such treatments seek to treat the person individually and
holistically, addressing deficits with medical or chemical means.25 Using biomedical treatments
to alleviate sensory processing impairments include treating food sensitivities by employing

19

Autism Spectrum Disorders, Treatment. Center for Disease Control. May 24, 2012. Available at,
http://www.cdc.gov/ncbddd/autism/treatment.html.
20

Id.

21

Id.

22

Id.

23

Id. See also, Why Should I Consider Biomedical Treatment for Autism? Treating Autism. Available at,
http://www.treatingautism.co.uk/why-biomedical/.
24

Kenneth Bock. Integrative Medicine. Rhinebeck Health Services. Available at,
http://www.rhinebeckhealth.com/rhc/integ_med.php.
25

Id.
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special diet plans, such as gluten free and casine free diets.26 Another aspect to biomedical
treatment is treating vitamin deficiencies with supplements, which address deficiencies for
example in amino acids and detoxifying the body of metals.27 Biomedical treatment can also
include using pharmaceuticals to treat symptoms of hyperactivity.28 Problems with the digestion
system are prevalent in children with ASD.29 There are strong indicators that a healthy digestive
system allows for proper cognitive function referred to as the mind-gut connection.30 The goal of
biomedical treatment is to alleviate digestive problems attributed to children with ASD reducing
many of the symptoms causing social and cognitive impairments.31
Unfortunately, despite clinical case studies indicating the positive impact that biomedical
approaches have on ASD’s, insurance providers have managed to exclude coverage for such
treatment(s) claiming them to be complementary or alternative treatment (CAM) and not
medically necessary.32 Yet, hope is not lost. Further research is currently underway, which will
ultimately prove biomedical treatment is effective and an essential part of an effective treatment

26

Holly Bortfeld. GFCFSF Diet on a Budget. Talk About Curing Autism. July 7, 2010. Available at,
http://www.tacanow.org/family-resources/gfcfsf-diet-on-a-budget/.
27

James B. Adams. Summary of Biomedical Treatment for Autism. Autism Society. http://www.autismsociety.org/living-with-autism/treatment-options/summary-of-biomedical.html.
28

Id.

29

Autism and GI Disorders. Autism Speaks. Available at, http://www.autismspeaks.org/whatautism/treatment/treatment-associated-medical-conditions/gi-disorders.
30

The Gut-Brain Connection. Harvard Health Publication. March 27, 2012.
http://www.health.harvard.edu/healthbeat/the-gut-brain-connection.
31

James B. Adams. Summary of Biomedical Treatment for Autism. Autism Society. http://www.autismsociety.org/living-with-autism/treatment-options/summary-of-biomedical.html.
32

What Is Complementary and Alternative Medicine? National Center for Complementary and Alternative
Medicine. NCCAM Pub No.: D347 Date Created: October 2008 Last Updated: July 2011
http://nccam.nih.gov/health/whatiscam.
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plan for ASD’s.33 With substantial empirical evidence, the judiciary and legislature alike will be
compelled to require insurance providers to cover the cost of such proven beneficial treatments.
One hurdle in requiring insurance coverage for biomedical treatment is that each child
responds differently to treatment.34 For that reason, finding the appropriate combination of
services for one child requires significant amounts of time and money. Subsequently, insurance
providers are reluctant to cover treatment for autism. Previously, insurance providers fought to
exclude treatments such as speech, occupational therapy, and physical therapy, claiming they are
not medically necessary for the treatment of ASD’s, but these treatments are now required to be
covered.35 Many states have continued with insurance reform and now have insurance mandates
requiring Applied Behavioral Therapy (ABA) to be covered for treatment of severe Autism,
which was also vehemently opposed by insurance providers.36 This national trend towards
providing more coverage for ASD’s suggests that biomedical treatment, despite having yet to be
required under coverage, will have a place as a covered therapy in the near future.37 States
33

See, Study to Explore Early Development (SEED). Centers for Disease Control and Prevention. Available at,
http://www.cdc.gov/ncbddd/autism/seed.html. See also, Autism Speaks Announces $6.9 Million in New
Biomedical Research Grants. Autism Speaks. Available at, http://www.autismspeaks.org/about-us/pressreleases/autism-speaks-announces-69-million-new-biomedical-research-grants. See also, Yale School of Medicine.
Yale Child Study Center. Available at, http://medicine.yale.edu/childstudy/autism/research.
34

Pervasive Developmental Disorders Information Page. National Institute of Neurological Disorders and Stroke.
National Institutes of Health. Available at, http://www.ninds.nih.gov/disorders/pdd/pdd.htm.
35

29 U.S.C.A. § 1185a (West). See also, Angela Barner, Unlocking Access to Insurance Coverage for Autism
Treatment, 6 J.L. Econ. & Pol'y 107 (2009). (Policy established in a settlement from Hatch v. Blue Cross Blue
Shield of Minnesota “entitled Pervasive Development Disorders: Identification, Evaluation, and Treatment, defines
pervasive developmental disorders (PDD) to include autism.”).
36

MaryAnne Lindeblad. Health Care Authority Approves ABA Therapy for Medicaid Children Diagnosed with
Autism. Washington State Health Auhtority. Available at, http://www.hca.wa.gov/news_release/health-careauthority-approves-aba-therapy-for.html. See also, Paul Frysh. Moving Out of State to get Autism Treatment. Cnn.
Available at, http://www.cnn.com/2010/HEALTH/09/17/autism.aba.legislation/index.html.
37

State Initiatives. Autism Speaks. Available at, http://www.autismspeaks.org/advocacy/states.
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should mandate insurance providers to cover biomedical treatment for children with ASD,
because the treatment is beneficial and safe. Expanding insurance coverage will provide the
child and their family with a better quality of life, and will also reduce the symptoms of their
impairments allowing them to reach fuller potential.
Autism is a serious national health concern. Federal and state governments both support
research on risk detection, prevention, and ultimately a cure.38 Current treatments for Autism
may only be effective for a small subset of the ASD population, which raises conflict over who
should share in the cost. While ASD children and their families may only be a small subset of
society, the potential for Autism to occur in the majority of the population is on the rise, thus
more expansive insurance coverage for ASD treatments is necessary. Specifically, as innovative
treatment modalities for ASD’s are discovered and made available, the conflict over proper
allocation of costs will require legislative and judicial intervention.
Mandated access to biomedical treatment for children with ASD will require a sustained
effort at insurance reform. Assessing the benefits of biomedical treatment for children diagnosed
with PDD-NOS involves examining the negative impact of excluding this treatment from health
insurance coverage, the benefits to mandating private insurance coverage for biomedical
treatments for Autism, and possible approaches advocates can use when attempting to obtain
coverage for children with ASD. Part I provides an overview of Autism, its impact on families
and society, and various treatment modalities. Part II provides an overview of statistical data
which shows the benefits of a biomedical approach to treating ASD’s. Part III discusses the two
main positions insurance providers use to exclude biomedical treatment for ASD. Part IV
38

National Database for Autism Research. National Institutes of Health. Available at, http://ndar.nih.gov/. See also,
NIH Awards $100 Million in Autism Research Grants Funded by CARA. Autism Speaks. Available at,
http://www.autismspeaks.org/news/news-item/nih-awards-100-million-autism-research-grants-funded-cara.
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presents responses to the insurance provider’s positions for those advocating for insurance
coverage for biomedical treatment. Part V proposes possible options for insurance mandates
requiring coverage for biomedical treatment for ASD’s. Part VI concludes this papers purpose,
which is to advocate for the expansion of private insurance coverage to include biomedical
treatment for PDD-NOS.
AUTISM DEFINED.

I.

Autism is a neurological disorder thought to be caused by a biological predisposition to
Autism (genetic abnormality), which is triggered or enhanced by environmental factors, which
result in a disruption in the neurological development during early prenatal stages. 39 There is
still unrest as to the exact cause of Autism, but the effects are known. Autism is a lifelong
disorder that causes global developmental delays. Children with ASD have physical, mental,
and social impairments, which can significantly limit their daily living capabilities.40 Onset can
be detected as early as infancy such as an infant unresponsive to social stimulus and failing to
meet typical developmental milestones. Alternatively, infants may progress normally until
around 15 – 24 months and then either stop progressing further (usually the case with a higher
functioning diagnosis), or they can completely regress to infantile like behavior (typically
associated with a more severe autistic diagnosis), both of which are also indicators of ASDs.41
Obtaining an official diagnosis for Autism usually requires an analysis of the history of the child
and family, as well as, a series of tests conducted by a neurologist or a pediatric

39

Autism Fact Sheet. Office of Communications and Public Liaison. National Institute of Neurological Disorders
and Stroke. Last updated March 20, 2012. http://www.ninds.nih.gov/disorders/autism/detail_autism.htm
40

Id.

41

Id.
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neuropsychologist.42 The neuropsychologist will also access the child’s personal capabilities
according to the DSM-IV.43 ASDs are generally separated by three main categories previously
discussed, autism (most severe), PDD-NOS (less severe), or Asperger’s (usually high
functioning).44 Those suffering the most severe impairments typically have substantial barriers
in all three areas such as physical limitations effecting daily living like immature walking style
or low muscle tone, lower mental capacity, limited memory retention or limited comprehension
ability, and social limitations such as inability to communicate verbally, extreme behavioral
episodes, and rapid movement of hands, legs, or arms.45 Children who display the above
symptoms are diagnosed with Autism.46 Children with these severe limitations have proven to
progress in their development through intense early intervention. Unfortunately, even with a
rigorous course of treatment these children will likely remain rather dependent on caregivers
throughout their lives.47
Alternatively, a diagnosis of Asperger’s is an ASD but is reserved for children with
higher cognitive ability, sometimes with exceptional ability in a particular area of study, but
42

Autism Spectrum Disorders (ASDs) Screening and Diagnosis. Center for disease Control and Prevention.
Available at, http://www.cdc.gov/ncbddd/autism/screening.html.
43

Diagnostic Criteria. Centers for Disease Control and Prevention. Available at,
http://www.cdc.gov/ncbddd/autism/hcp-dsm.html.
44

Autism Spectrum Disorders (ASDs) Facts. Center for disease Control and Prevention. Available at,
http://www.cdc.gov/ncbddd/autism/facts.html.
45

Angela Barner, Unlocking Access to Insurance Coverage for Autism Treatment, 6 J.L. Econ. & Pol'y 107 (2009).
See also, Autism Symptoms. Mayo Clinic. Available at,
http://www.mayoclinic.com/health/autism/DS00348/DSECTION=symptoms.
46

Id.

47

Adults with Autism. National Alliance on Mental Illness. Available at,
http://www.nami.org/Template.cfm?Section=Helpline1&Template=/ContentManagement/ContentDisplay.cfm&Co
ntentID=66015.
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with rather significant social impairments resulting in an inability to acquiesce to social norms
such as hygiene, make eye contact, and often fail to develop empathy.48 Children with mild
Asperger’s will often go undiagnosed and even those with more intense Asperger’s symptoms
will often go without treatment because children and adults with Asperger’s are given social
acceptance because they are generally able to achieve academic achievement.49

A third

diagnosis on the Autism Spectrum is Pervasive Developmental Disorder, will be the focus of
this article.
A.

PERVASIVE DEVELOPMENTAL DISORDER (PDD-NOS) DISTINGUISHED.

“Having autism can be extremely hard. However, having high-functioning autism can sometimes
be even harder. [For example,] when a high-functioning autistic person communicates with a
stranger, oftentimes the stranger doesn’t realize the person has a disability; [therefore], I’ve been
looked upon as odd, scared, and sometimes even stupid. My name is Russell Lehmann; I have
high-functioning autism.”50

A child diagnosed with Pervasive Developmental Disorder – Not Otherwise Specified
(PDD-NOS), suffers from a combination of two impairment categories.51 The impairments of a
child with PDD-NOS are less disabling than a more severe Autism diagnosis and children with
PDD-NOS are usually considered high functioning.52 A child with PDD-NOS is more aware of
people and situations around them, and thus, will be able to interact with others more

48

Asperger Syndrome Signs and Symptoms. KidsHealth.org. Available at,
http://kidshealth.org/parent/medical/brain/asperger.html#.
49

Id.

50

Russell Lehmann. The Poet. Available at, https://www.squag.com/696/. See also, Russell Lehmann. Inside Out.
Available at, http://www.autisticpoet.com/bio.php.
51

Asperger’s Syndrome. Autism Society. Available at, http://www.autism-society.org/about-autism/aspergerssyndrome/.
52

Walker DR, Thompson A., Zwaigenbaum L., Golderberg J., Bryson SE, Mahoney WJ., Strawbridge CP, and
Szatmari P. Specifying PDD-NOS: a comparison of PDD-NOS, Asperger Syndrome and Autism. Available at,
http://www.ncbi.nlm.nih.gov/pubmed/14726723.
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regularly.53 Still, as expressed by Russell Lehmann above children with PDD-NOS will
experience limitations to such interactions.54 Even within a diagnosis of PDD-NOS there is a
wide range of impairment levels. Children with PDD-NOS may end up with significantly
limited functional ability in society as adults. Thus, establishing a comprehensive early
intervention plan is important for treating PDD-NOS.55 Other children with PDD-NOS, typically
those who receive the right combination of services early in their development, can become
rather independent as adults; working, marrying, and having children of their own.56 One barrier
to receiving early treatment is that children with PDD-NOS are often misdiagnosed with ADHD
or even Bi-Polar disorder because some symptoms for these very different disorders manifest
themselves similarly in children with PDD-NOS.57 Additionally, some children do not receive
early intervention because they are not diagnosed with PDD-NOS occasionally because parents
and doctors chose to wait and see if the child grows out of the symptoms on their owm.58
Importantly, many children are not receiving appropriate and comprehensive early intervention

53

Diagnostic Classifications. Autism Society. Available at, http://www.autism-society.org/aboutautism/diagnosis/diagnostic-classifications.html.
54

Russell Lehmann. The Poet. Available at, https://www.squag.com/696/. See also, Russell Lehmann. Inside Out.
Available at, http://www.autisticpoet.com/bio.php.
55

Autism. American Academy of Child and Adolescent Psychiatry. Autism Research Center. Available at,
http://www.aacap.org/cs/autism_resource_center/faqs_on_autism.
56

Autism Spectrum Disorder Relationships and Sexuality. Centre for Autism. Avialable at,
https://www.middletownautism.com/fs/doc/publications/mca-booklet-0005-wlink.pdf.
57

Kenneth Bock and Cameron Stauth. Healing the New Childhood Epidemics. 2008 Ballantine Books Trade.
Random House, Inc. New York, New York.
58

Pervasive Developmental Disorder. Emory University. Available at,
http://www.psychiatry.emory.edu/PROGRAMS/autism/pdd.html#3.
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to help them progress because the treatments they need are not being covered by insurance
providers.59
B. WITHOUT

A CURE, WHAT TREATMENTS CAN BE USED TO REDUCE THE BLIGHTING

SYMPTOMS OF AUTISM?

The most basic treatments for ASD include the combination of three services abbreviated
as ST, OT, and PT. Speech therapy (ST) is best provided multiple times per week with
individual and group sessions.60 Many children with ASD require ST for improvements in
articulation, chewing and swallowing, help with auditory processessing, as well as,
categorization of words and sounds to provide them with skills so they can better involve
themselves in general conversation.61 Additionally, group speech therapy sessions teach peer
conversational skills and techniques such as not cutting someone off, using proper eye contact,
and recognizing when to end the conversation.62 Speech therapy for a child with ASD is critical
to their overall development as our academic system is heavily dependent on language
acquisition.63
Another common course of treatment for ASD is Occupational Therapy (OT). OT
improves fine motor skills like learning how to properly use a pencil and scissors or button

59

See section IV. PRIVATE INSURANCE PROVIDER’S STRONGEST ARGUMENTS FOR EXCLUDING BIOMEDICAL
page 24.

TREATMENT FROM COVERAGE on
60

See, Isa Marrs. Speech and Language Therapy. Available at, http://www.speechlanguagefeeding.com/speechlanguage-therapy-westchester/.
61

Id.

62

Id.

63

See also, Communication for a Liftime. American Speech-Language-Hearing Association. Available at,
http://www.asha.org/public/.
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clothing, which requires hand strengthening exercises.64 OT also helps gross motor skills, such
as overall planning of body movement and awareness of one’s body in space, ability to sit in a
chair plus endurance to sit upright in a chair or the ability to stand independently without leaning
on someone or something without throwing one’s body on the floor for sensory stimulation.65
Using OT to address sensory processing issues significantly reduces many of the social
impairments children with ASD exhibit, which prevent them from connecting with their peers.66
Specifically, this OT approach addresses with dynamic equilibrium issues and teaches
techniques to the child to help them ease over or under stimulation issues.67 This approach has
proven to reduce “stimming,” or rapid body movements, which result in social isolation, and
also reduces symptoms similar to those exhibited with ADHD, which is the reason for much
misdiagnosis.68 Unfortunately, OT for sensory processing is only offered by private OT clinics,
not by public schools, and is similarly not covered by private health insurance providers.69
Physical therapy (PT) for ASDs addresses low muscle tone, toe walking and the like.70
Providing PT to a child with ASD can help to lengthen their stride while walking, increase their
running speed, balance and coordination for riding a bike, develop their muscle strength for

64

Sue Seiler. Kidabilities. Copyright 2007. Available at, http://www.kidabilities.com/services.htm.

65

Id.

66

Id.

67

Id.

68

See, Sue Seiler. Kidabilities. Copyright 2007. Available at, http://www.kidabilities.com/faqs.htm.

69

Florence Clark. Essay: The Current Status of Sensory Integration Therapy. AOTA Blogs. August 7, 2012.
http://otconnections.aota.org/aota_blogs/b/aota_presidential_blog/archive/2012/08/07/essay-the-current-status-ofsensory-integration-therapy.aspx.
70

See, Patient Care Overview. Kennedy Krieger Institutte. Available at, http://www.kennedykrieger.org/patientcare/patient-care-centers/center-autism-and-related-disorders?gclid=CLTKwuvw6rQCFUbf4AodgDEAdw.
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sitting, standing, rolling kicking, and teach them how to catch and throw a ball properly.71 It is
imperative that children with ASD receive PT as it is essential to their daily lives, allowing them
to participate in more activities with their peers and improving their overall quality of life.72
Further, regular Behavioral therapy/psychological counseling is beneficial to children
with ASD teaching them skills necessary to understand and identify their own emotions and
show empathy to others.73 Through psychological counseling children with ASD learn how to
better deal with the severe stress, depression, and anxiety, which are prevalent will experience
throughout their lives, thus reducing many of the symptoms, induced during stress.74
Additionally, Applied Behavioral Therapy (ABA) is used for children with the most
severe impairments.75 This is a micro-approach, which breaks down each essential life skill into
multiple steps that are innate to most children but need to be taught to children on the
spectrum.76 This repetitive and basic approach has proven significantly effective and allows
even the most severely impaired children to begin interaction with the world around them, and
71

See, Treatments & Therapies. Autism Speaks. Available at, http://www.autismspeaks.org/family-services/toolkits/100-day-kit/treatments-therapies.
72

Treatment & Interventions. Southwest Autism Research & Resource Center. Available at,
http://autismcenter.org/treatment_interventions.aspx#q5.
73

See, ADHD Autism Psycholigical Service and Advocacy. Available at,
http://www.aapsa.net/Website/Team/Staff.aspx. See also, Autism Therapists in Massachusetts (MA). Psychology
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teaches them basic functioning skills like how to hold a spoon in order to feed themselves. 77
Once a child begins to respond positively to aba therapy this will continue in conjunction with
the other more traditional forms of therapy.
Currently, ST, OT, and PT are considered traditional treatment plans for autism and thus
private insurance providers are now required to cover them.78 After much contention, ABA
therapy is also now required to be covered. All of these treatments seek to improve the
symptoms, which impair the functional lives of people with autism through.79 Still, none of these
treatments address the underlying cause of the symptoms, the neurological malfunction.
Biomedical Treatment for ASD involves physiological analysis and treatment.80 Many
professionals believe that there is a strong correlation between the neurological impairments of a
child with ASD and the digestive issues common for a child with ASD.81 The biomedical
approach involves assessing the overall physical function of the child through testing their blood
and stool for deficiencies in certain nutrients and identifying any substances that should not be
there such as heavy metals or overproduction of candida.82 After testing, children are often
placed on strict diets to account for any food sensitivities they may have, as well as, prescribed
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nutritional supplements in order to counteract any deficiencies identified.83 Occasionally, the
use of psychotropic drugs to address symptoms of ADHD is used in conjunction with other
biomedical treatments.84 The goal of biomedical treatment is to purify the body to allow for
optimal cellular function so the body can heal itself. Currently, biomedical treatment is not
covered by private insurance providers.85
Distinguishable from biomedical treatments are homeopathic approaches, which include,
acupuncture, music therapy, and dog therapy.86 These approaches are merely supplemental and
should not be used to replace the other therapies discussed above. These approaches are not
medical as they do not address the underlying causes of the impairment and do not change
cellular function or body chemistry of the child. Further, the cost of these approaches tends to
be minimal and their effect is more to encourage emotional well-being.87 These avenues of
treatment are typically excluded by insurance providers.88 Biomedical treatment should not be
considered part of this group of alternative treatment as biomedical approaches actually change
the chemical composition of the child’s body and biomedicine is implemented and monitored by
a physician.
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While, neither a preventative strategy, nor a cure for autism has been discovered, early
intervention involving a combination of the above referenced therapies has shown to
significantly reduce the symptoms and impairments inflicting children with ASD, thus allowing
these “recovered” children to lead relatively independent adult lives. More expansive insurance
coverage should be provided to children with ASD.
C. IMPACT OF AUTISM: HIGH HOPES LEAD TO LARGE DEBT.
While the benefits of biomedical treatment for children diagnosed with PDD-NOS will
only help a small subset of the population, the negative impact of excluding this treatment from
health insurance coverage is immense. Overall, treating autism is a heavy financial burden,
running as much as $72,000 for one child per year, or over 3.2 million over the course of that
child’s lifespan.89 If insurance providers are required to allocate this cost more evenly across the
entire pool of insured, it will only slightly increase rates but the benefit is significantly helping
the individual families effected by ASD.90 One study revealed that total expenditures per 10,000
covered lives associated with ASDs increased 142.1% over a 5-year period.91 With costs of care
rising annually, and the current cost of treating a child with ASD, this is a significant amount of
money for a family to have to pay. One family even admits that in ten years the cost of their sons
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treatments for ASD toppled one million dollars.92 While the average cost of treating a child with
ASD is 3 to 5 million per child, this cost can be reduced by two thirds by implementing
appropriate early intervention.93 By helping children who have ASD but are high functioning,
like the sub population of children with PDD-NOS, we can significantly reduce the total lifespan
cost for children with ASD.
Specifically, biomedical treatment should be covered by insurance providers because the
treatment is beneficial and will result in lowering the overall cost of caring for a child with ASD
because they will progress faster in their development. Also, requiring insurance coverage for
biomedical treatment is important because the treatment can be very costly for a family to have
to pay out of pocket. One study conducted by, “retrospective analysis of private health insurance
claims,” revealed that the average health care expenditures in annual inpatient, outpatient, and
prescription drug expenditures for children under seventeen with an ASD increased 20.4% from
$4,965 per patient in 2000, to $5,979 per patient in 2004.94 Many families have started to ask
family, friends, and even strangers to help donate to help pay for biomedical treatments for their
child with ASD.95 Without insurance coverage, families will not be able to access appropriate
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early intervention for their children and thus the cost of caring for that child will remain high
throughout adulthood.
Early therapeutic intervention for ASD is the key difference between developing into an
adult needing full-time care and an adult capable of living an independent productive life
without expensive aide. Thus, even though these treatments may be expensive, they are well
worth the cost early in life, because they will increase the possibility that the child with PDDNOS will be independent as an adult, able to hold a job and be self-sustaining therefore reducing
their economic dependence on the system as a whole.96 Caring for a child with ASD is a social
concern and the financial burden should be shared accordingly. This cost should not be left to
the families that happen to have a child with autism because society as a whole is universally
vulnerable to autism.

Thus, the benefit to mandating insurance coverage for biomedical

treatments for ASD is that it will protect the insured so they can effectively find a treatment plan
that their child responds to, and in turn, can achieve a greater level of overall health and less
reliance on costly treatments in the long run.
II. BIOMEDICAL TREATMENT IS EFFECTIVE IN TREATING PDD-NOS.
Treating ASD with biomedicine is based on the application of the principals of natural
science to clinical practices through physiological interventions, which reduce the symptoms
associated with one's inability to tolerate environmental stressors.97 Such treatments seek to
treat the child individually and holistically, addressing imbalances with medical or chemical
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means.98 The biomedical approach to ASD aims to address the genetic, epigenetic, and
biochemical issues that are the underlying causes of the child’s symptoms.”99 Epigenetics
studies the changes in DNA expressions which cause impairments when the underlying DNA
sequence has not changed.100 ASD’s are thought to be caused by a genetic mutation that occurs
during prenatal development possibly triggered by environmental factors. Thus, environmental
factors may be what has significantly impacted the DNA to cause it to express itself differently
when there is no specific genetic reason (DNA sequence is not different).101 Environmental
insults (at this point specific causes are unknown but believe to be a combination of chemicals,
metals, radiation, and preservatives) lead to biochemical changes manifesting themselves
through behavioral impairments and result in a vicious cycle of developmental delays.102
Treating ASD with a biomedical approach aims to interrupt the cycle in an effort to restore
proper cell function.103
Biomedical treatment alleviates digestive problems, which are common to children with
ASD, and by altering their body chemistry to reduce many impairing social and cognitive
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symptoms.104 Particularly, using biomedical treatments for Autism involves removing
environmental toxins present in the body and repairing any damage which has resulted.105
Biomedical treatment for ASD typically includes treatment of food sensitivities by employing
special diet plans (such as gluten free casine free diet), treating vitamin deficiencies with
supplements (deficiencies in amino acids and detoxifying the body of metals), and even
pharmaceuticals (to treat symptoms of hyperactivity).106
Specifically, food sensitivity has been linked to improper bodily processes, thus by
identifying which foods are causing reactions and eliminating those from the diet some children
show improvement in overall functioning (including the improvement of cognitive ability).107
This is supported by empirical data provided by multiple studies. One United Kingdom study
showed positive development in children with ASD put on gluten and casein-free diets
(GFCF).108 Additional studies prove that daily supplements of vital nutrients, such as those
104
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containing amino acids, often effectively reduce symptoms associated with ASD, because they
are converted into neurotransmitters, which can alleviate mental disorders caused by chemical
imbalances in the brain such as depression. 109 One study in particular conducted on a 9-year-old
boy with autism proved he responded positively to the nutritional supplements, Dimethylglycine
and a combination of a large dose of Vitamin B6 (Pyridoxal HCl) and Magnesium. 110 Still, the
reported findings from this study cannot be generalized because every child may react
differently or need a different combination of supplements. A case study on an individual child
such as this provides preliminary evidence enhancing an accumulating body of literature
supporting the theory and efficacies of nutritional supplements in ASDs.111 Further, a
randomized, double-blind, placebo-controlled study conducted over a three month period
administered vitamin and mineral treatment to 141 children and adults with ASD showed that
the supplement group had significantly greater improvements than the placebo group on the
Parental Global Impressions-Revised, which showed decreased hyperactivity, less tantrumming,
and increased ability in receptive language.

112

This suggests that vitamin and mineral

109

Ibrahim KS, El-Sayed EM. Proposed remedies for some developmental disorders. Toxicol Ind Health. 2012 Feb
2. Available at, http://www.ncbi.nlm.nih.gov/pubmed/22301819.
110

Xia RR. Effectiveness of nutritional supplements for reducing symptoms in autism-spectrum disorder: a case
report. J Altern Complement Med. 2011 Mar;17(3):271-4. Source Department of Physical Therapy, Creighton
University, available at, http://www.ncbi.nlm.nih.gov/pubmed/21417812. Two family members independently
administered the The Autism Treatment Evaluation Checklist (ATEC) at baseline and at 5 moths into treatment to
gauge improvement. The ATEC evaluates four areas: communication, sociability, sensory/cognitive awareness,
and behavior. The lower the scores are, the less severe the symptoms are. The ATEC evaluations showed that the
changes in total ATEC were from 63 at pretest to 33 at post-test, and from 64 at pretest to 30 at post-test,
respectively. These changes represented reductions of 47.6% and 53.1%. The school teachers also noticed
improvements in various areas consistent with the ATEC evaluations.
111
Id.
112

Adams JB, et al. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 2011
Dec 12;11:111. Autism/Asperger's Research Program, Arizona State University, Tempe, available at
http://www.ncbi.nlm.nih.gov/pubmed/22151477. Vitamin/mineral supplementation is beneficial in improving the
nutritional and metabolic status of children with autism, including improvements in methylation, glutathione,

Harper 23

supplement are a reasonable and effective course of therapy to consider for most children and
adults with ASD.113 Nutritional supplements have proven effective for treating ASD for specific
children, but biomedical treatment goes beyond just nutritional assessment and treatment.
Pharmaceutical interventions, have also proven a useful biomedical approach.
Supporting this, the article Therapies for Children with Autism Spectrum Disorder synthesized
data from medical studies conducted from January 2000 to May 2010 the results of which
determined antipsychotic drugs Risperidone and Aripiprazole aide improvement in “challenging
behavior that includes emotional distress, aggression, hyperactivity, and self-injury.”114 Some of
the cases in the above referenced study revealed some mild side effects (emphasized as not
being significant). Still, the results supports the use of medical intervention as a part of an early
intensive behavioral and developmental plan to improve cognitive performance, language skills,
and adaptive behavior in children with ASD.
These studies provide a basis for linking biomedical treatments to symptom reduction for
ASD. Still, in order to require private insurance companies to cover biomedical treatment more
studies will need to be done in order for biomedical treatments to be sufficiently accepted in the
medical community to require coverage. Otherwise sufficient studies will need to be done to
provide enough empirical evidence to show that despite not being accepted as treatment it
oxidative stress, sulfation, ATP, NADH, and NADPH. The supplement group had significantly greater
improvements than did the placebo group on the PGI-R Average Change. (PGI-R, Average Change, p = 0.008), and
on the subscores for Hyperactivity (p = 0.003), Tantrumming (p = 0.009), Overall (p = 0.02), and Receptive
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should be covered because the data shows it is effective and safe. Additional studies are
currently being conducted with results soon to be released. 115
III.

PRIVATE

INSURANCE

PROVIDER’S

STRONGEST

ARGUMENTS

FOR

EXCLUDING

BIOMEDICAL TREATMENT FROM COVERAGE.

“What is it about the little boy;
he acts different in every way
What is it about the little boy;
they say it won’t go away
What is it about the little boy?
What is the cause for concern?
What it is about the little boy,
has a diagnosis we’ve learned
Now we know about the little boy
So now where do we turn?
Now we know about the little boy;
there is so much to learn
So, who will help the little boy?
Insurance says no way!
Who will help the little boy
If we cannot pay?”116

Private health insurance may be governed through federal legislation, ERISA or through
state regulation of smaller employers.117 ASD has been explicitly included in the mental health
parity law as a neurological disorder which requires coverage by insurance providers.118
Nonetheless, Insurance coverage is not absolute. In many cases insurance coverage is restricted
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to particular services, preferred health care providers, and can also have annual monetary
limits.119 Further, private insurance providers often limit coverage to statutory mandates which
set the minimum for emergency care, preventative care, and chronic illness care.120
Unfortunately, many private insurance plans are allowed to create major loopholes, which
insurance providers use to deny insurance coverage for many treatments. Insurance Providers
exclude ASD treatments claiming them to be Complementary and Alternative Medicine and not
medically necessary.121
A. INSURANCE PROVIDERS EXCLUDE COVERAGE FOR BIOMEDICAL TREATMENT BY CLAIMING IT IS
“COMPLIMENTARY ALTERNATIVE MEDICINE” (CAM).
Insurance providers avoid coverage by claiming services are Complementary and
Alternative Medicine (CAM). CAM is defined as, “a group of diverse medical and health care
systems, practices, and products that are not presently considered to be part of conventional
medicine.”122
Typical exclusions of CAM treatments involve acupuncture, massage, hypnotherapy, and
probiotics.123 Private insurance carriers have been allowed the freedom to exclude many useful
medical treatments under this broad exclusion. This reallocation of medical expenditure has
heavily burdened individual citizens. According to the American Hospital Assoc., in 2007 US
consumers spent 33.9 billion out-of-pocket for CAM including both the purchase of CAM
119
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products and materials as well as the estimated 354.2 million visits to CAM practitioners. 124
Additionally, even hospitals which primarily focus on emergency and terminal illness are
increasing the availability of typical CAM services in house, as well as, increasing their referrals
for CAM treatments.125 Insurance providers trying to prevent additional costs for treatments for
ASDs have a stronger argument in excluding music therapy or dog therapy (even though both of
these have proven effective in reaching a child with ASD), than they do with blocking
biomedical treatment administered by an Medical Doctor.
B. INSURANCE PROVIDERS EXCLUDE BIOMEDICAL TREATMENT FROM COVERAGE BY CLAIMING IT
IS NOT “MEDICALLY NECESSARY.”

A common provision in health insurance policies is to require that covered services,
equipment or supplies be medically necessary.126 Conversely, services that are not medically
necessary are excluded from coverage.127 If the terms of the contract are unambiguous as to how
the insurance provider defines a medically necessary treatment then the treatment is evaluated
according to the terms of the contract. For example, some policies define "medically necessary"
as a service or treatment in accordance with accepted medical standards in the area, which
services could not be omitted without an adverse effect on the patient. 128 If, on the other hand,
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the contract is ambiguous then the contract will be strictly interpreted in favor of the insured and
will consider safety and efficacy to determine if the treatment is a covered benefit.129
To determine if a treatment is medically necessary, the courts will first consider the
terms of the policy and the nature of the treatment. 130 To evaluate the nature of the treatment,
the court may consider; appropriateness of the level or intensity of the service, the individual
patients condition and if the request treatment is appropriate to treat that condition, and whether
the therapy is “merely performance enhancing or discretionary in nature.”131 The court will also
consider if the terms of the contract are clear and unambiguous.
One example of an insurance policy attempting to define medical necessity gives the
insured’s the right, “to have a candid discussion about appropriate or medically necessary
treatment options for your condition, regardless of cost or benefit coverage.”132 While it is
beneficial to know about medically necessary treatment options by ones doctor, if they are not
going to be covered by the insurance provider, the discussion itself does the patient little good.
Still, the plan also provides insured’s the right to receive medically necessary specialty care,133
and allows the insured to request a waiver for medically necessary prescriptions that are not
covered under the plan.134 To determine if a treatment of service is medically necessary, this
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plan has medical staff comprised of physicians, registered nurses and other health care providers
that “review requests for health care services to determine if the requested service is medically
necessary.”135 The plan fails to provide a specific rubric or the actual consideration the medical
staff uses in order to make such a determination.
Further, in April 2000, Aetna (one of the largest health insurance providers), agreed to a
settlement contract that stipulated medically necessary as,
"health services and supplies that under the applicable standard of care are
appropriate: (a) to improve or preserve health, life, or function; or (b) to slow the
deterioration of health, life, or function; or (c) for the early screening, prevention,
evaluation, diagnosis or treatment of a disease, condition, illness or injury."
Included in this definition is the cost effectiveness of services and supplies. A
treatment is cost effective if it is the least expensive medically necessary
treatment selected from two or more treatments that are "equally effective."136
This definition would provide for great leeway in arguing that biomedical treatment for
autism is a cost effective way to change their overall function, improve their health, and
ultimately reduce costs of their services in the future. As there is no standard legislative
definition of the term medically necessary, all therapies will be considered by assessing the
terms of the contract.
Still, in the absence of a definition for medically necessary treatment in the plan, or when
there is an ambiguity in the terms of the plan, courts will adopt their own assessment for what is
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a medically necessary and thus covered treatment under that particular plan. The second circuit
adopted an individual assessment of medically necessary procedures positing,
“unless the contrary is specified, the term “medical necessity” must refer to what
is medically necessary for a particular patient, and hence entails an individual
assessment rather than a general determination of what works in the ordinary
case.”137
Some courts have determined that, “medical necessity is strictly a contractual term in
which a patient’s physician must prove that a procedure is medically appropriate and
efficacious.”138 Other courts have defined medical necessary as, “a treatment that is commonly
recommended, or not outside the mainstream of the usual customary practice of medicine, or
meets the common standard of care.”139
IV.

MODALITIES FOR LAWYERS ADVOCATING FOR COVERAGE FOR THEIR CLIENTS.
Insurance providers try to escape coverage for ASD treatments by claiming they are not

medically necessary and/or that they are experimental. In order for advocates to successfully
convince the judiciary that biomedical treatment for ASDs should be covered by private
insurance providers, advocates must prove that the treatment is either accepted in the medical
community as a legitimate treatment and/or that the treatment is beneficial and not dangerous.
Advocates seeking to expand benefits that children with ASD receive should emphasize
the public policy behind protecting this vulnerable class of people. “Exclusion of [health benefit]
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coverage based solely because of [a] disability is against legislative intent.”140 While there is
currently no mandate that explicitly requires insurance carriers to cover biomedical treatment,
denying children with ASD access to this treatment is contrary to public interest. “Every child is
born with the potential to develop those skills necessary to life in society.141 Children afflicted
with ASD cannot achieve their full potential without a comprehensive treatment plan specific to
their individual needs, and biomedical treatments have become an essential part of such a plan.
Early intense treatments can help restore children with ASDs’ potential.142 The court in,
Micheletti v. State Health Benefits Comm'n, further posited that when a treatment is not exotic
nor economically wasteful it should be covered.143 Further, the court emphasized that including
treatment for a small number of children with ASD would not necessary overly burden the
provider or the entire community of insured.144 It is important for advocates to remember the
vulnerability of the population seeking treatment, the fact that the cost of covering them will not
be overly burdensome on the insurance provider or on the population of insured overall, and that
it is the intent of the legislature to protect the rights of those inflicted with lifelong impairments
such as ASD.
Advocates seeking remedy in the judicially for biomedical treatment coverage will likely
be facing an insurance provider that claims biomedical treatment is excluded under the policies
140

Micheletti v. State Health Benefits Comm'n, 913 A.2d 842, 844 (App. Div. 2007).

141

Id.

142

Id.

143

Id. (the necessity of the speech and occupational therapy treatment in this case was not disputed).

(“developmental defines childhood”).

144

Murray v. State Health Benefits Comm'n, 767 A.2d 509, 510 (App. Div. 2001). (The plaintiff sought
reimbursement of 170 dollars for colonic hydrotherapy which was excluded under the experimental provisions of
the contract, although similar to an enema which is covered by the insurance it was different in the administration of
the procedure).
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CAM provision. Many policies consider treatments, which are not common or “outside the
prevailing opinion within the appropriate specialty,” to be complimentary, and thus excluded.145
Also, if treatments are still in the clinical trials or research stages and being used as educational
tools then providers typically try to exclude the treatment as CAM as well.146 Where the terms of
the contract are not ambiguous as to what constitutes an experimental treatment, and the
treatment in question is in phase II clinical trial or less and the insured signs a consent form,
which specifically states the treatment is for research and/or is experimental the insurance
company was not required to cover this treatment.147 Exclusions under CAM were originally
allowed in order to ensure safety and efficacy of treatments. Yet, courts have recognized that the
use of alternative medical treatments is expanding, and thus they should not be excluded from
insurance coverage without careful consideration. If treatments are commonly accepted among
alternative medicine practitioners they should not be excluded solely because “traditional
doctors do not yet utilize the treatment or are completely unfamiliar with the practice.” 148 This

145

Id.

146

Parsons v. Sisters of Charity of Leavenworth Health Sys., Inc., 2011 WL 2144894 (D. Mont. May 31, 2011).
Coverage for a treatment that was proven partially successful through clinical trials was denied for a twenty year
old suffering from a chronic autoimmune disease with no cure called Crohn’s disease, which attacks the
gastrointestinal tract. Several reasons to conclude this treatment was in fact experimental (peer review article stating
randomized studies needed to be conducted still, partial approval of the procedure by FDA not full, the consent
letter for the clinical trial explicitly stated that it was an experimental research study, and severe possibility of
serious health risks with the procedure). In order to enter into the clinical trial the plaintiff was required to sign a
consent form which contains specific language stating it was an agreement to participate in an “experimental
research study” which involves a “risky” procedure which “may not work” and may “result in death.” The consent
form also state that even though this procedure was full approved by the FDA for some transplants for cancer it was
not approved for the treatment of crohns disease yet, thus it was not standard within the medical community for this
purpose.
147

Murray v. State Health Benefits Comm'n, 767 A.2d 509, 510 (App. Div. 2001).

148

Id. See also, Michael H. Cohen, Holistic Health Care: Including Alternative and Complementary Medicine in
Insurance and Regulatory Schemes, 28 Ariz.L.Rev. 83, 156 (1996). “Insurer inclusion of alternative and
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growing acceptance for CAM treatments is exhibited by medical schools, which now teach
alternative approaches to accompany traditional medical practices. 149 Another consideration in
evading CAM exclusions is that if the alternative treatment is potentially dangerous for the
patient the court likely proceed with caution and require more studies before ruling the treatment
must be covered by insurance.150 This is not a concern with biomedical treatment. Biomedical
treatment does not have significant side effects that would cause a court to take pause in
determine the safety of the treatments. Further, any proposed therapy must be viewed in its
entirety to discern whether the treatment qualifies as experimental.151 The courts have much
difficulty in determining if a treatment should be considered experimental and thus excludable
as they are recognizing that alternative treatments can be cost effective and as medicine
continues with new innovation the courts have more difficulty in denying coverage for more
efficient and more economic treatments.152

complementary therapies is likely to expand as therapies gain acceptance and credibility, and gain support by data
showing that such treatment can contribute to health so as to minimize insurers' overall costs.”
149

Kathleen M. Boozang, Western Medicine Opens the Door to Alternative Medicine, 24 Am.J.L. & Med. 185,
186-187 (1998). “As more doctors are taught these techniques the availability and utilization of alternative
treatments will increase.”

sufficient evidence for the Commission to conclude that this particular
treatment was potentially unsafe and inefficacious for the purposes prescribed, and it was not
error to consider the gastroenterologist as the “appropriate specialty” to determine whether this
particular treatment requires further evaluation.”).
150

Id. at 514-15. (“there was

151

Kopicki v. Fitzgerald Auto. Family Employee Benefits Plan, 121 F. Supp. 2d 467, 469-70 (D. Md. 2000). See
also, Hendricks and Martin. 39 F.3d at 514–515. Id. at 477.
152

Vellios v. IPRO, External Review Agent, 765 N.Y.S.2d 222, 223 (Sup. Ct. 2003). (In order to resolve
whether new alternative treatments should be covered by insurance, “the prudent course of action might be
to establish some sort of regional cooperative committees comprised of oncologists, internists, surgeons,
experts in medical ethics, medical school administrators, economists, representatives of the insurance
industry, patient advocates and politicians. Through such a collective task force perhaps some consensus
might be reached concerning the definition of experimental procedures, as well as agreement on the
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Advocates need to convince the court that despite having yet to be proven efficacious it
is in the public’s best interest for insurance providers to cover biomedical treatment.153 Typically
the plaintiffs’ burden of proof in trying to obtain coverage under a perspective insurance plan
requires that the plaintiff fulfill the “medically necessary” provision. Occasionally, insurance
providers will explicitly enumerate requirements for a treatment to be medically necessary. The
determination of coverage should not be based solely on the “likelihood of success” but instead
should be a balance between the irreparable harm to the plaintiff against the harm to the
defendant and if the balance goes towards the plaintiff the likelihood of success test is
displaced.154 The position of the Health Care Financing Administration (HCFA) on the
procedure may also factor into the analysis.155 As a final element or consideration, “public
interest favors the preservation of life and a patient receiving medical benefits to which he is
entitled.”156
Advocates should emphasize to the court that private insurance providers’ decisions to
exclude coverage are given less discretion then state benefits providers. State benefits plans are

procedures, which are so cost prohibitive that requiring insurers to cover them might result in the collapse
of the healthcare industry.” Article 49 of the Insurance Law, determinations of health care plans to deny
coverage for medical treatment to their insureds’.”).
153

Fuja v. Benefit Trust Life Ins. Co., 18 F.3d 1405, 1407 (7th Cir. 1994).

154

Kopicki v. Fitzgerald Auto. Family Employee Benefits Plan, 121 F. Supp. 2d 467, 479-80 (D. Md. 2000). See
also, Blackwelder Furn., 550 F.2d at 194.
155

Id. 476.

156

Id.. (quoting), Accord Dozsa v. Crum & Forster Ins. Co., 716 F.Supp. 131, 140 (D.N.J.1989). (“In Wilson, the
court found that the total absence of Phase III clinical trials on the therapy in question did not justify a categorical
determination that such a procedure was experimental or investigational. 65 F.3d at 365–66. Rather, the court found
that “a therapy could become standard practice in the medical community before it had been proven more effective
than traditional treatment ....where a highly promising treatment for a terminal illness is known to be harmless, but
has yet to be proven efficacious in prospective, randomized testing.” Wilson, 65 F.3d at 366. Id. 481.”).
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provided more discretion for limiting or excluding coverage as necessary to “avoid inequity and
unnecessary utilization.”157 Courts have recognized that state health plans and commercial
insurance plans are distinguishable because the state commission “must balance its obligations
of meeting the health care needs of its members with a fiduciary obligation to make the program
cost effective.”158 Private insurance carriers do not have the incentive to keep the program cost
effective. Consequently, ambiguous provisions will be construed against commercial policies as
an adhesion contract (unlike deference given to state plan administrative decisions).”159
Additionally, the court will limit the discretion given to insurance provider’s decisions to
exclude treatment when there is a conflict of interest. A conflict of interests exists if the plan
administrator is given sole authority to review and make decisions on plan terms and on benefit
coverage determinations.160 When there is a conflict of interest, ambiguities are to be construed
against the insurers.161
Biomedical treatment for autism does have a place in the insurance provider’s coverage
plan. There have been randomized tests done that show that biomedical treatment can be
effective in treating ASDs. Additionally, there is a movement towards acceptance of alternative
157

Markiewicz v. State Health Benefits Comm'n., 915 A.2d 553, 561 (App. Div. 2007).

(arbitrary and

capricious review of decisions).
158

Id.

159

Murray v. State Health Benefits Comm'n, 767 A.2d 509, 511 (App. Div. 2001) (quoting) Heaton v. State Health
Benefits Comm'n, 624 A.2d 69 (App.Div.1993). see also, Kievit v. Loyal Protective Life Ins. Co., 170 A.2d 22
(1961). Thus, for commercial plans the insurance providers decision to exclude experimental treatments will not be
given as much discretion by the courts, providing plaintiffs with a lower threshold to prove the private insurance
companies decisions to exclude was wrong.
160

Kopicki v. Fitzgerald Auto. Family Employee Benefits Plan, 121 F. Supp. 2d 467, 473 (D. Md. 2000). See also,
Killian v. Healthsource Provident Administrators, Inc., 152 F.3d 514, 521 (6th Cir.1998) (finding when an
employer “both funds and administers the plan at issue, there is an actual and apparent conflict.”).
161

Id. at 475. (referencing) Bailey v. Blue Cross/Blue Shield of Virginia, 866 F.Supp. 277 (E.D.Va.1994).
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medicine, in particular holistic approaches to alleviating impairing physiological symptoms.
Considering that there is a lower differential standard for private insurance companies than the
one given to state insurance, the judiciary should require private insurance carriers to cover
biomedical treatment for children with ASDs.
Advocates attempting to get judicially mandated coverage for biomedical treatment for
ASDs by private insurance carriers have an uphill battle. Advocates should emphasize the public
interest in protecting the rights to comprehensive treatment benefits, of children with ASD, as
they are a vulnerable community. They should also emphasize that providing children with ASD
better treatment will reduce the overall costs of caring for them, as they will require less services
as they continue to progress developmentally. Further, by ensuring such treatment for children
with PDD-NOS who are typically higher functioning, they possibly can become completely
independent as adults.

As more clinical studies come out, advocates must prove that the

treatment is accepted in the medical community as a legitimate treatment. Further, advocates
should emphasize that the treatment is beneficial and not dangerous and thus should be covered
even if it has not yet been accepted by mainstream medicine.
V.

POSSIBLE LEGISLATIVE REFORM.
Biomedical treatment will have a relatively low cost per child but can have a cumulative

heavy burden on insurance companies. Additionally, treatment is extremely individualized and
may or may not work for any individual child. Thus, insurance providers are reluctant to cover
this expense. Regardless of insurance providers resistance, the rise in ASD has prompted federal
and state mandates expanding insurance coverage for ASD treatments to expand.162 Further,
162

Justine Redmen. Mom Wins Fight For Autism Insurance. CNN.com. Available at,
http://www.cnn.com/2008/HEALTH/conditions/04/01/autism.insurance/index.html. See also, South Carolina:
Frequently Asked Questions About the Autism Insurance Reform Law (Ryan’s Law). Available at,
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once additional clinical trials are conducted on biomedical approaches to reduce ASD
symptoms, insurance companies will eventually be required to cover the cost of these treatments
as biomedical approaches for ASD become more widely accepted in the mainstream medical
community or as the empirical evidence clearly shows a health benefit and no dangerous side
effects.
One possible approach to achieving mandated coverage would be to propose legislation
similar to that of Ryan’s Law but instead of advocating for ABA therapy, the new legislation
would explicitly require biomedical treatment for ASD to be coverage by private insurance.163 A
compromising limitation could be to set yearly limitations on the amount the insurance provider
will cover towards biomedical treatments.164 Another possible requirement would be for
insurance companies pay for initial testing, with a referral from the primary care physician, to
determine if that particular child requires or would benefit from biomedical treatment. Moving
forward, if the doctor at the initial visit/testing phase recommends a course of action then those
subsequent treatment expenses will be required to be covered up to the annual policy limit.
Many state legislatures so far have also included age limits suggesting mandatory coverage up
until a certain age.165 Possibly adding a simple sentence to these already implemented mandates
to include coverage nutritional supplements and medications would also be beneficial. For new
state mandates, an age limit for biomedical treatment coverage is not beneficial because children
http://ddsn.sc.gov/providers/medicaidwaiverservices/pdd/Documents/PDDManual/Ryan%27s%20Law%20FAQ.pd
f
163

Id.

164

For visitation limits see, N.J. Admin. Code 11:4-57.3. For Coverage limits see, N.J. Stat. Ann. § 17B:27-46.1ii
(West).
165

Tex. Ins. Code Ann. § 1355.015 (West). (coverage from date of diagnosis until the age of nine). See also, Alaska
Admin. Code tit. 7, § 135.220 ( coverage for those “under 21 years of age with a severe behavioral disorder”).
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likely will still need this treatment as their symptoms increase and decrease as the child goes
through various life stages. A beneficial proposal to expand coverage may read:
“At a minimum, a health benefit plan must provide coverage as provided by this
section to an enrollee who is diagnosed with autism spectrum disorder:”166
(1)

initial testing by a specialist for biomedical treatments for autism
including but not limited to blood and stool testing for food
sensititivies, digestive track issues, testing for chemical
imbalances, testing for vitamin deficiencies, and any test that is
prescribed in order to access and implement biomedical treatment.

(2)

Physician recommended medications or nutritional supplements
used to address symptoms of autism spectrum disorder.167

(3)

Comprehensive testing/evaluations to reassess the child’s progress,
to cover at least two comprehensive tests/evaluations per year (one
comprehensive test every six months). The specialist shall have the
discretion to determine, which tests shall be conducted for the biannual evaluations. The specialist will have the ability to
test/evaluate more frequently than twice per year.

“The benefits provided pursuant to this subsection shall be provided to the same
extent as for any other medical condition under the policy,” and cannot be
excluded as being non-restorative, except that the provider may implement certain
exclusions and/or requirements such as:168
(A)

Treatment limits for biomedical treatments of $10,000 per year.

(B)

Require a prescription for the visit to the specialist by the primary
care physician.169

166

Tex. Ins. Code Ann. § 1355.015 (West).

167

Id.

168

N.J. Stat. Ann. § 17B:27-46.1ii (West). (“The benefits provided pursuant to this subsection shall not be denied
on the basis that the treatment is not restorative.”).
169

N.J. Admin. Code 11:4-57.3 (preauthorization requirement).
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(C)

Limit the amount of visits to the nutritional specialist to 20 visits
per year and can count phone consultations that the doctor charges
as a visit in the visitation limit.170

(D)

Providers may choose to only cover the initial specialist visit and
testing and upon recommendation with explanation from the
specialist the provider will then be required to cover the
recommended course of action including (2) form this subsection
up until any explicit treatment limits in section (A) of this
subsection.

Legislative reform for biomedical treatment is a distant reality considering more clinical
studies need to be done in order to have enough evidence that this treatment is successful, that is
it not harmful, and that it is accepted in the medical community.171 Still, a basic proposal similar
to the one posited above seems to be a fair compromise between the needs of children with ASD
and the needs of insurance providers to keep expenses low. A mandate similar to this will
require children with ASD to be allowed to at least get initial testing to see if they may benefit
from a biomedical treatment program and ensure that if the specialist determines they will
benefit, that the insurance provider will cover up to 10,000 in expenses towards the treatment
annually. While this may not cover the complete cost of biomedical treatment for every child
with ASD, it is certainly a major help to families who are currently paying completely out of
pocket for their children’s biomedical treatment. Further, this proposal protects insurance
providers interests by allowing an annual limit, and limiting the amount of comprehensive

170

Id. (annual visitation limits allowed).

171

Dreher W. Evidence-based medicine and public health law: statutory health insurance. Z Arztl Fortbild
Qualitatssich. 2004 Sep;98(6):489-93. Available at, http://www.ncbi.nlm.nih.gov/pubmed/15527192. Positing that
quality of medical services should be a consideration in determining if a treatment is medically necessary, and that
quality of services is the main concern of Evidence-based Medicine (EbM).
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testing to twice annually. Ultimately, a proposal like this will help to make biomedical treatment
an accessible treatment option for children with ASD, thus allow children with ASD to access
to a more comprehensive treatment plan earlier in life so they can achieve larger developmental
gains and have lower health care costs throughout their lives, which should be the ultimate goal
of health insurance reform for this vulnerable population.
VI.

CONCLUDING

THOUGHTS:

BIOMEDICAL

TREATMENT

IS

A

USEFUL

MEDICAL

TREATMENT THAT SHOULD BE COVERED BY INSURANCE IN ACCORDANCE WITH THE
PUBLIC POLICY OF PROVIDING ACCESS TO BENEFICIAL TREATMENT THAT IS NOT
DANGEROUS.

Children with developmental disabilities are the most vulnerable community in our
society and should receive the highest level of protection, and the most significant access to
health care. ASD is unpredictable, it crosses socioeconomic boundaries and it can cause severe
impairments, which significantly reduces life opportunities for many children. Thus, expanding
coverage to help this community is the obligation of society as a whole. Particularly children
diagnosed with PDD-NOS have the potential to lead independent and productive adult lives but
they experience very real barriers to their physical, educational, and social development. If there
is a possibility those barriers can be alleviated through biomedical treatment, the small cost is
worth the great gain, the life of a child.
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